Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Staphylococcus aureus | UDP-N-acetylmuramoylalanine-D-glutamate ligase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium tuberculosis | Probable UDP-N-acetylmuramoylalanine-D-glutamate ligase MurD | Get druggable targets OG5_132024 | All targets in OG5_132024 |
Treponema pallidum | UDP-N-acetylmuramoylalanine--D-glutamate ligase (murD) | Get druggable targets OG5_132024 | All targets in OG5_132024 |
Chlamydia trachomatis | UDP-N-acetylmuramoylalanine--D-glutamate ligase | Get druggable targets OG5_132024 | All targets in OG5_132024 |
Mycobacterium ulcerans | UDP-N-acetylmuramoyl-L-alanyl-D-glutamate synthetase | Get druggable targets OG5_132024 | All targets in OG5_132024 |
Mycobacterium leprae | Probable UDP-N-acetylmuramoylalanine-D-glutamate ligase MurD | Get druggable targets OG5_132024 | All targets in OG5_132024 |
Wolbachia endosymbiont of Brugia malayi | UDP-N-acetylmuramoylalanine-D-glutamate ligase | Get druggable targets OG5_132024 | All targets in OG5_132024 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Wolbachia endosymbiont of Brugia malayi | UDP-N-acetylmuramyl pentapeptide synthase | UDP-N-acetylmuramoylalanine-D-glutamate ligase | 449 aa | 368 aa | 23.4 % |
Mycobacterium ulcerans | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanyl ligase MurF | UDP-N-acetylmuramoylalanine-D-glutamate ligase | 449 aa | 366 aa | 20.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0347 | 0.3316 | 1 |
Onchocerca volvulus | 0.0431 | 0.4263 | 0.5 | |
Wolbachia endosymbiont of Brugia malayi | UDP-N-acetylmuramoylalanine-D-glutamate ligase | 0.033 | 0.3123 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0431 | 0.4263 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 0.1043 | 0.2448 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0146 | 0.1043 | 0.1043 |
Mycobacterium ulcerans | UDP-N-acetylmuramoyl-L-alanyl-D-glutamate synthetase | 0.0416 | 0.4089 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 0.1043 | 0.2448 |
Echinococcus multilocularis | muscleblind protein | 0.0146 | 0.1043 | 0.1043 |
Treponema pallidum | UDP-N-acetylmuramoylalanine--D-glutamate ligase (murD) | 0.0416 | 0.4089 | 1 |
Echinococcus granulosus | geminin | 0.0347 | 0.3316 | 1 |
Mycobacterium tuberculosis | Probable UDP-N-acetylmuramoylalanine-D-glutamate ligase MurD | 0.0288 | 0.2643 | 1 |
Chlamydia trachomatis | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 0.0416 | 0.4089 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0431 | 0.4263 | 1 |
Mycobacterium leprae | Probable UDP-N-acetylmuramoylalanine-D-glutamate ligase MurD | 0.0288 | 0.2643 | 1 |
Brugia malayi | hypothetical protein | 0.0431 | 0.4263 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0347 | 0.3316 | 1 |
Echinococcus multilocularis | geminin | 0.0347 | 0.3316 | 0.3316 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 12.5 ug ml-1 | In vitro inhibitory activity against Staphylococcus aureus UDP-N-acetylmuramoyl-L-alanyl-D-glutamate synthetase | ChEMBL. | 12852973 |
IC50 (binding) | = 12.5 ug ml-1 | In vitro inhibitory activity against Staphylococcus aureus UDP-N-acetylmuramoyl-L-alanyl-D-glutamate synthetase | ChEMBL. | 12852973 |
IC50 (binding) | > 25 ug ml-1 | In vitro inhibitory activity against Staphylococcus aureus UDP-N-acetylmuramate dehydrogenase | ChEMBL. | 12852973 |
IC50 (binding) | > 25 ug ml-1 | In vitro inhibitory activity against Staphylococcus aureus UDP-N-acetylmuramoyl-L-alanine synthetase | ChEMBL. | 12852973 |
IC50 (binding) | > 25 ug ml-1 | In vitro inhibitory activity against Staphylococcus aureus UDP-N-acetylmuramate dehydrogenase | ChEMBL. | 12852973 |
IC50 (binding) | > 25 ug ml-1 | In vitro inhibitory activity against Staphylococcus aureus UDP-N-acetylmuramoyl-L-alanine synthetase | ChEMBL. | 12852973 |
logP (ADMET) | = 1.41 | Partition coefficient (logP) | ChEMBL. | 12852973 |
MIC (functional) | = 8 ug ml-1 | Minimum inhibitory activity against Staphylococcus pneumoniae GC1894 (PRSP) | ChEMBL. | 12852973 |
MIC (functional) | = 32 ug ml-1 | Minimum inhibitory activity against Enterococcus faecalis GC 2242 (VRE) | ChEMBL. | 12852973 |
MIC (functional) | = 64 ug ml-1 | Minimum inhibitory activity against Staphylococcus aureus GC 4543 (MSSA) | ChEMBL. | 12852973 |
MIC (functional) | = 64 ug ml-1 | Minimum inhibitory activity against Enterococcus faecalis GC 4555 (ATCC) | ChEMBL. | 12852973 |
MIC (functional) | = 128 ug ml-1 | Minimum inhibitory activity against Staphylococcus aureus GC 1131 (MRSA) | ChEMBL. | 12852973 |
MIC (functional) | = 128 ug ml-1 | Minimum inhibitory activity against Staphylococcus aureus GC 2216 (ATCC) | ChEMBL. | 12852973 |
MIC (functional) | > 128 ug ml-1 | Minimum inhibitory activity in presence of 4% bovine serum albumin against Staphylococcus pneumoniae GC1894 (PRSP) | ChEMBL. | 12852973 |
MIC (functional) | > 128 ug ml-1 | Minimum inhibitory activity against MSCNS GC 646 | ChEMBL. | 12852973 |
MIC (functional) | > 128 ug ml-1 | Minimum inhibitory activity against Escherichia coli GC 4559 | ChEMBL. | 12852973 |
MIC (functional) | = 128 ug ml-1 | Minimum inhibitory activity against Escherichia coli GC 4560 | ChEMBL. | 12852973 |
MIC (functional) | > 128 ug ml-1 | Minimum inhibitory activity against Escherichia coli GC 4559 | ChEMBL. | 12852973 |
MIC (functional) | = 128 ug ml-1 | Minimum inhibitory activity against Escherichia coli GC 4560 | ChEMBL. | 12852973 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.